Miracit (Butamirate CItrate)

Therapeutic Group : Bronchodilator & Antitussive

Presentation:

Each 5 ml syrup contains Butamirate Citrate INN 7.5 mg.

Pharmacology:

Butamirate citrate (Miracit), is a cough suppressant that is neither chemically nor pharmacologically related to opium alkaloids. It acts centrally by diminishing the toxigenic reflex and peripherally via a bronchospasmolytic activity enhanced by anti-inflammatory action. Butamirate Citrate also increases the spirometry indexes & blood oxygenation. Butamirate citrate (Miracit) does not induce habit-forming effects or dependence.

Indications:

Miracitis indicated in acute cough of any etiology, pre and post-operative cough sedation for surgical procedure and bronchoscopy.

Dosage & Administration:

Children 3 – 6 years: 5 ml 3 times daily.
Children 6 – 12 years: 10 ml 3 times daily.
Adolescents over 12 years: 15 ml 3 times daily.
Adults: 15 ml 4 times daily.

Contrainidications:

Hypersensitivity to the active substance.

Warning & Precautions:

Consult with doctor if any side effects may experience.

Side effects:

Butamirate is well tolerated. In rare cases, skin rash, nausea, diarrhea, dizziness has been reported. They disappear after reduction of the dosage or discontinuation of the drug.

Drug interaction:

Concomitant use with expectorants should be avoided.

Use in special groups:

Pregnancy & lactation:Butamirate should not be used in the first trimester of pregnancy. During the second and third trimesters of pregnancy, butamirate should be administered only if necessary, to use medicines.Butamirate Syrup should be carefully considered in case of breastfeeding.

Storage:

Store below 30°C, keep in dry place & protect from light.

Packing:

Each bottle contains 100 ml syrup.